Evaluation of Oral and Intravenous Route Pharmacokinetics, Plasma Protein Binding, and Uterine Tissue Dose Metrics of Bisphenol A: A Physiologically Based Pharmacokinetic Approach
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Bisphenol A (BPA) is a weakly estrogenic monomer used in the production of polycarbonate plastic and epoxy resins, both of which are used in food contact and other applications. A physiologically based pharmacokinetic (PBPK) model of BPA pharmacokinetics in rats and humans was developed to provide a physiological context in which the processes controlling BPA pharmacokinetics (e.g., plasma protein binding, enterohepatic recirculation of the glucuronide [BPAG]) could be incorporated. A uterine tissue compartment was included to allow the correlation of simulated estrogen receptor (ER) binding of BPA with increases in uterine wet weight (UWW) in rats. Intravenous- and oral-route blood kinetics of BPA in rats and oral-route plasma and urinary elimination kinetics in humans were well described by the model. Simulations of rat oral-route BPAG pharmacokinetics were less exact, most likely the result of oversimplification of the GI tract compartment. Comparison of metabolic clearance rates derived from fitting rat i.v. and oral-route data implied that intestinal glucuronidation of BPA is significant. In rats, but not humans, terminal elimination rates were strongly influenced by enterohepatic recirculation. In the absence of BPA binding to plasma proteins, simulations showed high ER occupancy at doses without uterine effects. Restricting free BPA to the measured unbound amount demonstrated the importance of including plasma binding in BPA kinetic models: the modeled relationship between ER occupancy and UWW increases was consistent with expectations for a receptor-mediated response with low ER occupancy at doses with no response and increasing occupancy with larger increases in UWW.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203 · cited 6×
“Estimates of its relative affinity for ERa compared to E2 range from 0.006% to 0.05% (Kuiper et al., 1998; Matthews et al., 2001; Nagel et al., 1998).”
BackgroundMethodInfluentialIkezuki, Y., Tsutsumi, O., Takai, Y., Kamei, Y., & Taketani, Y. (2002) · Human Reproduction · doi:10.1093/humrep/17.11.2839 · Cited by 886 · cited 1×
“Both blood BPAG and urinary BPAG are biomarkers of exposure that have been used to estimate human exposure to BPA (Arakawa et al., 2004; Ikezuki et al., 2002; Ouchi and Watanabe, 2002).”
BackgroundSun, Y., Nakashima, M. N., Takahashi, M., Kuroda, N., & Nakashima, K. (2002) · Biomedical Chromatography · doi:10.1002/bmc.161 · Cited by 118 · cited 9×
“Bisphenol A and BPAG pharmacokinetics have been characterized in several strains and sexes of rats, and in male and female humans, but they have been subject only to characterization by classical compartmental and non-compartmental analyses (Pottenger et al., 2000; Sun et al., 2002; Upmeier et al., 2000; Völkel et al.…”
BackgroundMethodInfluential
Cited by
Human exposure to bisphenol A (BPA)
Vandenberg, L. N., Hauser, R., Marcus, M., Olea, N., & Welshons, W. V. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2007.07.010 · Cited by 2,885
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
Lang, I. A. (2008) · JAMA · doi:10.1001/jama.300.11.1303 · Cited by 1,458
Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A
Vandenberg, L. N., Chahoud, I., Heindel, J. J., Padmanabhan, V., Paumgartten, F. J. R., & Schoenfelder, G. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901716 · Cited by 1,233
EFSA Panel on Food Contact Materials, E. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.3978 · Cited by 1,023
Environmental chemicals in pregnant women in the United States: NHANES 2003–2004
Woodruff, T. J., Zota, A. R., & Schwartz, J. M. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002727 · Cited by 930
Kang, J.-H., Kondo, F., & Katayama, Y. (2006) · Toxicology · doi:10.1016/j.tox.2006.06.009 · Cited by 875
Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06
Melzer, D., Rice, N. E., Lewis, C., Henley, W. E., & Galloway, T. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008673 · Cited by 572
“Following oral ingestion, BPA is not considered a persistent compound, but neither is it immediately cleared from the body, and there appears to be virtually continuous human exposure [46].”
BackgroundNTP‐CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A
Chapin, R. E., Adams, J., Boekelheide, K., Gray, L. E., Hayward, S. W., Lees, P. S. J., McIntyre, B. S., Portier, K. M., Schnorr, T. M., Selevan, S. G., et al. (2008) · Birth Defects Research Part B: Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20147 · Cited by 506
Dekant, W., & Völkel, W. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.12.008 · Cited by 488
Urinary, Circulating, and Tissue Biomonitoring Studies Indicate Widespread Exposure to Bisphenol A
Vandenberg, L. N., Chahoud, I., Heindel, J. J., Padmanabhan, V., Paumgartten, F. J. R., & Schoenfelder, G. (2012) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232012000200015 · Cited by 430
Stahlhut, R. W., Welshons, W. V., & Swan, S. H. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.0800376 · Cited by 422
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A
Hengstler, J. G., Foth, H., Gebel, T., Kramer, P.-J., Lilienblum, W., Schweinfurth, H., Völkel, W., Wollin, K.-M., & Gundert-Remy, U. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.558487 · Cited by 346
Melzer, D., Osborne, N. J., Henley, W. E., Cipelli, R., Young, A., Money, C., McCormack, P., Luben, R., Khaw, K.-T., Wareham, N. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.069153 · Cited by 303
Similarity of Bisphenol A Pharmacokinetics in Rhesus Monkeys and Mice: Relevance for Human Exposure
Taylor, J. A., vom Saal, F. S., Welshons, W. V., Drury, B., Rottinghaus, G., Hunt, P. A., Toutain, P.-L., Laffont, C. M., & VandeVoort, C. A. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002514 · Cited by 278
vom Saal, F. S., & Welshons, W. V. (2006) · Environmental Research · doi:10.1016/j.envres.2005.09.001 · Cited by 256
Healy, B. F., English, K. R., Jagals, P., & Sly, P. D. (2015) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/jes.2015.49 · Cited by 59
Metadata
- Authors
- Teeguarden, J. G., Waechter, J. M., Clewell, H. J., Covington, T. R., & Barton, H. A.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-02
- Volume
- 85
- Issue
- 2
- Pages
- 823-838
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2147462150
- Cited by
- 151
- References
- 4
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.